Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis
Abstract Prolactinomas represent the most common type of secretory pituitary neoplasms, with a therapeutic management that varies considerably based on tumour size and degree of hyperprolactinemia. The aim of the current study was to evaluate the relationship between serum prolactin (PRL) concentrat...
Enregistré dans:
Auteurs principaux: | Bianca M. Leca, Maria Mytilinaiou, Marina Tsoli, Andreea Epure, Simon J. B. Aylwin, Gregory Kaltsas, Harpal S. Randeva, Georgios K. Dimitriadis |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3d1f5a9291d64e33bc4fcb33f13e7454 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Somatic SF3B1 hotspot mutation in prolactinomas
par: Chuzhong Li, et autres
Publié: (2020) -
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis
par: Yunzhi Zou, et autres
Publié: (2021) -
Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas
par: Lukas Andereggen, et autres
Publié: (2021) -
Connections between prolactin and ovarian cancer.
par: Amira Alkharusi, et autres
Publié: (2021) -
The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas
par: Shuman Wang, et autres
Publié: (2021)